Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
(A) We investigated the role of JCAD in the pathogenesis of angiogenesis in vitro. In HUVEC cells, knock-down of JCAD induced the significant decrease of Tube formation, viability assesed by WST-1. (B) Role of JCAD in the angiogenesis in vivo. We used tumor growth model, and compared the angiogenesis between JCAD-/- mouse and WT mice. We observed significant decrease of tumor angiogenesis and impaired angiogenesis maturation assessed by SMA satining.
|